A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.
Clinical trial NCT00558298 · COMPLETED
Trial details
- NCT number
- NCT00558298
- Sponsor
- Janssen, LP
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-02-01
- Enrollment
- 811
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.